1 |
Poste. (2001). Molecular Diagnostics: A Powerful New Component of the Healthcare Value Chain, Expert Rev. Mol. Diag, 1 (1).
|
2 |
Singh and Abrol. (2017). In-Vitro Diagnostics (IVDs) Innovations for Resource-Poor Settings: The Indian Experience, African Journal of Science Technology Innovation and Development, 9 (5), 617-636.
DOI
|
3 |
ICMR. (2020). Advisory: Newer Additional Strategies for COVID-19 Testing, 2020. https://www.icmr.gov.in/pdf/covid/strategy/New_additional_Advisory_23062020_3.pdf
|
4 |
ICMR. (2021) Role of evidence-based &well-researched guidance is vital in defeating the pandemic, e-Samvaad. https://www.icmr.gov.in/pdf/press_realease_files/Newsletter_English_May_2021.pdf.
|
5 |
Kennedy. (1994). The relationship between Science and Technology. Research Policy, 23, 477-486.
DOI
|
6 |
Carlsson and Stankiewicz. (1991). On the Nature, Function and Composition of Technological Systems, Journal of Evolutionary Economics, 1 (2), 93-118.
DOI
|
7 |
AdvaMedDx & DxInsights. (2013). Introduction to Molecular Diagnostics: The Essentials of Diagnostics Series, https://dx.advamed.org.
|
8 |
Mierlo, Arkesteijn, and Leeuwis. (2010). Enhancing the Reflexivity of System Innovation Projects with System Analyses, American Journal of Evaluation, 31(2), 143-161.
DOI
|
9 |
Garcia. (2000). Science and Technology and their role in Human Health in Developing Countries, Mem Inst Oswaldo Cruz, Rio de Janeiro,95 (1), 5-7.
DOI
|
10 |
Ghosh et al. (1997). Business Opportunities in Medical Diagnostics in India: A market report. Biotech Consortium India Limited.
|
11 |
Musiolik et al. (2012). Networks and Network Resources in Technological Innovation Systems: Towards a Conceptual Framework for system building,Technological Forecasting and Social Change, 79(6), 1032-1048.
DOI
|
12 |
OECD. (1997). National Innovation Systems, Paris.
|
13 |
Bergek, Jacobsson, and Sanden. (2008). Legitimation and Development of Positive Externalities: Two key Processes in the Formation Phase of Technological Innovation Systems, Technology Analysis & Strategic Management, 20 (5), 575-592.
DOI
|
14 |
Constance. (2010). The future of Molecular Diagnostics; Innovative Technologies Driving Market Opportunities in Personalized Medicine, Business Insights Ltd.
|
15 |
Guglielmi. (2020). Researchers are scrambling to find new ways to diagnose the coronavirus and churn out millions of tests a week - a key step in returning to relative normality, Nature, 583, 506-509.
DOI
|
16 |
Woolthuis et al. (2005). A System Failure Framework for Innovation Policy Design, Technovation, 25 (6), 609-619.
DOI
|